Brief: Ipsen To Acquire Imcheck Therapeutics
Oct 22 (Reuters) - Ipsen SA IPN.PA: IPSEN TO ACQUIRE IMCHECK THERAPEUTICS, EXPANDING ITS LEADERSHIP IN ONCOLOGY, STRENGTHENING ITS PIPELINE TO BUY IMCHECK THERAPEUTICS FOR 350 MILLION EUROS TOTAL POTENTIAL CONSIDERATION UP TO 1 BILLION EUROS TRANSACTION IS EXPECTED TO CLOSE BY END OF Q1 2026 Source text: ID:nGNX5GqW3V Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio